143 related articles for article (PubMed ID: 8943806)
1. 2-hydroxyestrone: the 'good' estrogen.
Bradlow HL; Telang NT; Sepkovic DW; Osborne MP
J Endocrinol; 1996 Sep; 150 Suppl():S259-65. PubMed ID: 8943806
[TBL] [Abstract][Full Text] [Related]
2. Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.
Bradlow HL; Davis DL; Lin G; Sepkovic D; Tiwari R
Environ Health Perspect; 1995 Oct; 103 Suppl 7(Suppl 7):147-50. PubMed ID: 8593862
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancer.
Bradlow HL; Sepkovic DW; Telang N; Tiwari R
In Vivo; 2011; 25(4):585-8. PubMed ID: 21709000
[TBL] [Abstract][Full Text] [Related]
4. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
[TBL] [Abstract][Full Text] [Related]
5. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer.
Yuan F; Chen DZ; Liu K; Sepkovic DW; Bradlow HL; Auborn K
Anticancer Res; 1999; 19(3A):1673-80. PubMed ID: 10470100
[TBL] [Abstract][Full Text] [Related]
6. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.
Michnovicz JJ; Bradlow HL
Nutr Cancer; 1991; 16(1):59-66. PubMed ID: 1656396
[TBL] [Abstract][Full Text] [Related]
7. Estrogen metabolites and the risk of breast cancer in older women.
Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
[TBL] [Abstract][Full Text] [Related]
8. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol.
Newfield L; Goldsmith A; Bradlow HL; Auborn K
Anticancer Res; 1993; 13(2):337-41. PubMed ID: 8390800
[TBL] [Abstract][Full Text] [Related]
9. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
Bentz AT; Schneider CM; Westerlind KC
Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
[TBL] [Abstract][Full Text] [Related]
10. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
[TBL] [Abstract][Full Text] [Related]
11. Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites.
Lord RS; Bongiovanni B; Bralley JA
Altern Med Rev; 2002 Apr; 7(2):112-29. PubMed ID: 11991791
[TBL] [Abstract][Full Text] [Related]
12. Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or beta-naphthaflavone: a comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods.
Sepkovic DW; Bradlow HL; Michnovicz J; Murtezani S; Levy I; Osborne MP
Steroids; 1994 May; 59(5):318-23. PubMed ID: 8073445
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent.
Bradlow HL; Sepkovic DW; Telang NT; Osborne MP
Ann N Y Acad Sci; 1999; 889():204-13. PubMed ID: 10668495
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of indole-3-carbinol in women: tolerability and effects.
Reed GA; Peterson KS; Smith HJ; Gray JC; Sullivan DK; Mayo MS; Crowell JA; Hurwitz A
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1953-60. PubMed ID: 16103443
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of cancer with indole-3-carbinol.
Brignall MS
Altern Med Rev; 2001 Dec; 6(6):580-9. PubMed ID: 11804548
[TBL] [Abstract][Full Text] [Related]
16. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women.
Fowke JH; Longcope C; Hebert JR
Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):773-9. PubMed ID: 10952093
[TBL] [Abstract][Full Text] [Related]
17. Catecholestrogen sulfation: possible role in carcinogenesis.
Adjei AA; Weinshilboum RM
Biochem Biophys Res Commun; 2002 Mar; 292(2):402-8. PubMed ID: 11906176
[TBL] [Abstract][Full Text] [Related]
18. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells.
Rahman KM; Aranha O; Glazyrin A; Chinni SR; Sarkar FH
Oncogene; 2000 Nov; 19(50):5764-71. PubMed ID: 11126363
[TBL] [Abstract][Full Text] [Related]
19. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans.
Michnovicz JJ; Adlercreutz H; Bradlow HL
J Natl Cancer Inst; 1997 May; 89(10):718-23. PubMed ID: 9168187
[TBL] [Abstract][Full Text] [Related]
20. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
